These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
369 related articles for article (PubMed ID: 17712416)
1. Candidate genes for expansion and transformation of hematopoietic stem cells by NUP98-HOX fusion genes. Palmqvist L; Pineault N; Wasslavik C; Humphries RK PLoS One; 2007 Aug; 2(8):e768. PubMed ID: 17712416 [TBL] [Abstract][Full Text] [Related]
2. Hox genes: from leukemia to hematopoietic stem cell expansion. Abramovich C; Pineault N; Ohta H; Humphries RK Ann N Y Acad Sci; 2005 Jun; 1044():109-16. PubMed ID: 15958703 [TBL] [Abstract][Full Text] [Related]
3. Linkage of Meis1 leukemogenic activity to multiple downstream effectors including Trib2 and Ccl3. Argiropoulos B; Palmqvist L; Yung E; Kuchenbauer F; Heuser M; Sly LM; Wan A; Krystal G; Humphries RK Exp Hematol; 2008 Jul; 36(7):845-59. PubMed ID: 18375036 [TBL] [Abstract][Full Text] [Related]
4. Constitutive activation of Flt3 and STAT5A enhances self-renewal and alters differentiation of hematopoietic stem cells. Moore MA; Dorn DC; Schuringa JJ; Chung KY; Morrone G Exp Hematol; 2007 Apr; 35(4 Suppl 1):105-16. PubMed ID: 17379095 [TBL] [Abstract][Full Text] [Related]
5. NUP98-NSD1 links H3K36 methylation to Hox-A gene activation and leukaemogenesis. Wang GG; Cai L; Pasillas MP; Kamps MP Nat Cell Biol; 2007 Jul; 9(7):804-12. PubMed ID: 17589499 [TBL] [Abstract][Full Text] [Related]
6. Leukemogenic properties of NUP98-PMX1 are linked to NUP98 and homeodomain sequence functions but not to binding properties of PMX1 to serum response factor. Hirose K; Abramovich C; Argiropoulos B; Humphries RK Oncogene; 2008 Oct; 27(46):6056-67. PubMed ID: 18604245 [TBL] [Abstract][Full Text] [Related]
7. Nup98-HoxA9 immortalizes myeloid progenitors, enforces expression of Hoxa9, Hoxa7 and Meis1, and alters cytokine-specific responses in a manner similar to that induced by retroviral co-expression of Hoxa9 and Meis1. Calvo KR; Sykes DB; Pasillas MP; Kamps MP Oncogene; 2002 Jun; 21(27):4247-56. PubMed ID: 12082612 [TBL] [Abstract][Full Text] [Related]
8. Induction of acute myeloid leukemia in mice by the human leukemia-specific fusion gene NUP98-HOXD13 in concert with Meis1. Pineault N; Buske C; Feuring-Buske M; Abramovich C; Rosten P; Hogge DE; Aplan PD; Humphries RK Blood; 2003 Jun; 101(11):4529-38. PubMed ID: 12543865 [TBL] [Abstract][Full Text] [Related]
9. Brief report: ectopic expression of NUP98-HOXA10 augments erythroid differentiation of human embryonic stem cells. Ji J; Risueño RM; Hong S; Allan D; Rosten P; Humphries K; Bhatia M Stem Cells; 2011 Apr; 29(4):736-41. PubMed ID: 21328509 [TBL] [Abstract][Full Text] [Related]
10. Transplantable cell lines generated with NUP98-Hox fusion genes undergo leukemic progression by Meis1 independent of its binding to DNA. Pineault N; Abramovich C; Humphries RK Leukemia; 2005 Apr; 19(4):636-43. PubMed ID: 15744344 [TBL] [Abstract][Full Text] [Related]
12. Differential and common leukemogenic potentials of multiple NUP98-Hox fusion proteins alone or with Meis1. Pineault N; Abramovich C; Ohta H; Humphries RK Mol Cell Biol; 2004 Mar; 24(5):1907-17. PubMed ID: 14966272 [TBL] [Abstract][Full Text] [Related]
13. Ontogeny stage-independent and high-level clonal expansion in vitro of mouse hematopoietic stem cells stimulated by an engineered NUP98-HOX fusion transcription factor. Sekulovic S; Gasparetto M; Lecault V; Hoesli CA; Kent DG; Rosten P; Wan A; Brookes C; Hansen CL; Piret JM; Smith C; Eaves CJ; Humphries RK Blood; 2011 Oct; 118(16):4366-76. PubMed ID: 21865344 [TBL] [Abstract][Full Text] [Related]
14. High level in vitro expansion of murine hematopoietic stem cells. Sekulovic S; Imren S; Humphries K Curr Protoc Stem Cell Biol; 2008 Jan; Chapter 2():Unit 2A.7. PubMed ID: 18770636 [TBL] [Abstract][Full Text] [Related]
15. NUP98 dysregulation in myeloid leukemogenesis. Moore MA; Chung KY; Plasilova M; Schuringa JJ; Shieh JH; Zhou P; Morrone G Ann N Y Acad Sci; 2007 Jun; 1106():114-42. PubMed ID: 17442773 [TBL] [Abstract][Full Text] [Related]
16. Manipulation of immune system via immortal bone marrow stem cells. Ruedl C; Khameneh HJ; Karjalainen K Int Immunol; 2008 Sep; 20(9):1211-8. PubMed ID: 18644831 [TBL] [Abstract][Full Text] [Related]
17. In-depth characterization of the microRNA transcriptome in a leukemia progression model. Kuchenbauer F; Morin RD; Argiropoulos B; Petriv OI; Griffith M; Heuser M; Yung E; Piper J; Delaney A; Prabhu AL; Zhao Y; McDonald H; Zeng T; Hirst M; Hansen CL; Marra MA; Humphries RK Genome Res; 2008 Nov; 18(11):1787-97. PubMed ID: 18849523 [TBL] [Abstract][Full Text] [Related]
18. HOXA4 induces expansion of hematopoietic stem cells in vitro and confers enhancement of pro-B-cells in vivo. Fournier M; Lebert-Ghali CÉ; Krosl G; Bijl JJ Stem Cells Dev; 2012 Jan; 21(1):133-42. PubMed ID: 21749220 [TBL] [Abstract][Full Text] [Related]
19. NUP98-HOXA9 induces long-term proliferation and blocks differentiation of primary human CD34+ hematopoietic cells. Takeda A; Goolsby C; Yaseen NR Cancer Res; 2006 Jul; 66(13):6628-37. PubMed ID: 16818636 [TBL] [Abstract][Full Text] [Related]
20. Enforced expression of NUP98-HOXA9 in human CD34(+) cells enhances stem cell proliferation. Chung KY; Morrone G; Schuringa JJ; Plasilova M; Shieh JH; Zhang Y; Zhou P; Moore MA Cancer Res; 2006 Dec; 66(24):11781-91. PubMed ID: 17178874 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]